Rabigen, εωέσιμο εναιώρημα για σκύλους και γάτες
Rabigen, εωέσιμο εναιώρημα για σκύλους και γάτες
Authorised
- Rabies virus, strain VP12, Inactivated
Product identification
Medicine name:
Rabigen, εωέσιμο εναιώρημα για σκύλους και γάτες
Active substance:
- Rabies virus, strain VP12, Inactivated
Target species:
-
Dog
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabies virus, strain VP12, Inactivated1.00/international unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
-
Not applicableno withdrawal period
-
- Cat
-
Not applicableno withdrawal period
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- VIRBAC
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 107538/15-11-2021/K-0252001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 16/07/2024
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 16/07/2024
How useful was this page?:
